Synergistic stimulation of prolactin release by phorbol ester, A23187 and forskolin

Biochem Biophys Res Commun. 1984 Sep 17;123(2):735-41. doi: 10.1016/0006-291x(84)90291-2.

Abstract

The effects of 12-0-tetradecanoyl-phorbol-13-acetate (TPA), A23187, forskolin and thyrotropin-releasing hormone (TRH) on prolactin release from GH4C1 cells were compared. TPA caused a 2-fold release, maximum after 6 or more min, that was sustained for 30 min or more. A23187 caused only a small and variable response that peaked within 4 to 6 min. Combination of TPA and A23187 caused a rapid 3- to 5-fold increase in release that declined slowly. TRH increased prolactin release 3- to 5-fold, reaching a maximum within 4 min, followed by sustained release at lower rates. Forskolin had little effect by itself, but potentiated release caused either by combined TPA and A23187, or by TRH. These data are consistent with a model in which two branches of the Ca2+ messenger system participate in the action of TRH, a calmodulin branch and a C-kinase branch that interact to cause large amounts of sustained release. Forskolin, by regulating the cyclic AMP content of the cell determines the set point around which the Ca2+ messenger system operates.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Calcimycin / pharmacology*
  • Calcium / metabolism
  • Cell Line
  • Colforsin
  • Cyclic AMP / metabolism
  • Diterpenes / pharmacology*
  • Drug Synergism
  • Phorbols / pharmacology*
  • Pituitary Neoplasms / metabolism*
  • Prolactin / metabolism*
  • Tetradecanoylphorbol Acetate / pharmacology*
  • Thyrotropin-Releasing Hormone / pharmacology
  • Time Factors

Substances

  • Diterpenes
  • Phorbols
  • Colforsin
  • Calcimycin
  • Thyrotropin-Releasing Hormone
  • Prolactin
  • Cyclic AMP
  • Tetradecanoylphorbol Acetate
  • Calcium